The timing of chemotherapy given to patients with SCLC does not have a statistically significant impact on OS. The timing of chemotherapy given to patients with SCLC does not have a statistically significant effect on OS. Chemotherapy-induced myelosuppression among patients with extensive-stage SCLC is poorly understood. The DeLLphi-301 study that evaluated patients with advanced SCLC. Lurbinectedin monotherapy is currently being studied in Jazz EMERGE 402 study in patients with metastatic SCLC. Researchers from the US and Italy have identified a biomarker that can distinguish between SCLC and SCC. Berzosertib plus topotecan significantly improves OS but not PFS in patients with relapsed small cell lung cancer. A study analyzed the efficacy and safety of radiotherapy in patients with SCLC with brain metastases. Co-targeting neuroendocrine and non-NE cells may help reduce small cell lung cancer progression. A study sought to ascertain the role of occupation in the risk of SCLC and adenocarcinoma in Spanish women. The results of a study that aimed to subclassify SCLC based on certain immunoexpressions. The group makes the distinction between non-small cell lung cancer, used as an umbrella term, and small cell lung cancer. In this podcast episode, The Oncology Brothers are joined by Dr. Estelamari Rodriguez, University of Miami Health ... Researchers investigated the effects of adding programmed cell death 1 (PD-1) inhibition to chemotherapy in patients ... Researchers set out to characterize survival outcomes in patients with small cell lung cancer (SCLC) treated with ... Immune checkpoint inhibitors (ICIs) are approved for treatment of small cell lung cancer (SCLC). However, according to ... In part one of the phase II/III RESILIENT trial, led by Luis Paz-Ares, researchers evaluated outcomes of second-line ... In a phase II trial, published in Thoracic Cancer, researchers evaluated the impact of apatinib as a maintenance ... Patients with extensive-stage small cell lung cancer (ES-SCLC) continue to face poor survival outcomes. Consolidative ... Dustin Diamond, who rose to fame in the 1990s for his role as Samuel “Screech” Powers on the hit television show ...